巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Moderna

    MRNA
    137.870
    4.410
    3.10%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Moderna - 延遲價格・最後更新於 18/05 12:14
    最高位
    144.070
    最低位
    136.290
    開市價
    --
    前收市價
    142.280
    成交量(千)
    172.31
    成交額(百萬)
    215.95
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    54,839.10
    市盈率
    4.050
    息率
    --
    差價
    --
    52週高低
    497.490 - 119.010
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Moderna
    證券代碼
    MRNA.US
    所屬板塊
    Biotechnology
    公司業務
    Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    發行量
    403020216
    公司總部
    200 Technology Square
    公司網址
    https://www.modernatx.com
    公司電郵
    Lavina.Talukdar@modernatx.com
    公司電話
    +1 617 714-6500

    抗疫概念股普遍上漲,拜登呼籲國會提供額外抗疫資金

    格隆匯·
    抗疫概念股普遍上漲,拜登呼籲國會提供額外抗疫資金

    抗疫概念股普遍上漲,拜登呼籲國會提供額外抗疫資金

    格隆匯·
    抗疫概念股普遍上漲,拜登呼籲國會提供額外抗疫資金

    疫苗新貴Moderna新CFO上任僅兩天就離職

    格隆匯·
    疫苗新貴Moderna新CFO上任僅兩天就離職

    疫苗新貴Moderna新CFO上任僅兩天就離職

    格隆匯·
    疫苗新貴Moderna新CFO上任僅兩天就離職

    美股抗疫概念股集體下挫 Moderna跌5%

    格隆匯·
    美股抗疫概念股集體下挫 Moderna跌5%

    關於

    Moderna(MRNA.US)所屬的行業板塊為Biotechnology。
    Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    詳細公司背景可參考: https://www.modernatx.com